Alignment Healthcare, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Alignment Healthcare, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.95B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $2.70B | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $1.82B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.43B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $1.17B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $959.22M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $756.96M | Mar 3, 2022 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2023 | $1.80B | Feb 27, 2024 |
| FY2023 | Dec 31, 2022 | $1.43B | Feb 27, 2024 |
| FY2023 | Dec 31, 2021 | $1.17B | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $955.39M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $753.97M | Mar 3, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($724.0K) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($128.04M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($148.02M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($149.55M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($195.29M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($22.93M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($44.73M) | Mar 3, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.75M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($101.56M) | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($127.82M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($128.64M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($178.07M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | ($5.26M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | ($29.48M) | Mar 3, 2022 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $443.41M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $371.37M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $307.43M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $295.65M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $290.99M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $156.40M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $110.13M | Mar 3, 2022 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $139.93M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $34.77M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | ($59.19M) | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | ($45.43M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | ($78.78M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $7.56M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $9.21M | Mar 3, 2022 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $26.78M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $41.42M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $36.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $23.77M | Feb 27, 2025 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.07B | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $782.06M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $591.88M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $633.86M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $630.90M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $338.50M | Mar 3, 2022 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $886.51M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $681.11M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $433.81M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $394.56M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $324.84M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $307.89M | Mar 3, 2022 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $179.28M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $99.85M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $156.95M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $238.13M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $306.04M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $30.61M | Mar 3, 2022 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $32.06M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $34.83M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $34.83M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $34.81M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $29.30M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $29.30M | Mar 3, 2022 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($1.01B) | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | ($1.01B) | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | ($880.26M) | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | ($732.24M) | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | ($582.69M) | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | ($379.57M) | Mar 3, 2022 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $575.82M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $432.86M | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | $202.90M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $409.55M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $466.60M | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | $207.31M | Feb 28, 2023 |
| FY2021 | Dec 31, 2019 | $86.48M | Mar 3, 2022 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $323.18M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | $321.43M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | $161.81M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $160.90M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | $150.62M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | $144.17M | Mar 3, 2022 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 28, 2023 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 0 | Feb 27, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 27, 2024 |
| FY2022 | Dec 31, 2020 | 0 | Feb 28, 2023 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 204.15M | Feb 27, 2026 |
| FY2025 | Dec 31, 2024 | 191.78M | Feb 27, 2026 |
| FY2024 | Dec 31, 2023 | 188.95M | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | 187.28M | Feb 27, 2024 |
| FY2022 | Dec 31, 2021 | 187.19M | Feb 28, 2023 |
| FY2021 | Dec 31, 2020 | 164.06M | Mar 3, 2022 |